Sealantium’s First Pivotal Phase 1/2 Trial Published in the American Journal of Surgery

Sealantium Medical is proud to announce the publication of its first pivotal Phase 1/2 randomized controlled multicenter trial in the peer-reviewed American Journal of Surgery. This landmark study compared sFilm-FS™, Sealantium’s dual-acting fibrin sealant patch, with Tachosil®, a leading hemostatic agent, in elective liver surgery. The results highlight a significant advance in surgical biomaterials: These […]

Sealantium & SimAbs Sign Quality Agreement, Advancing Toward GMP Manufacturing of sFilm-FS™

Sealantium Medical is proud to announce a key milestone in its collaboration with Belgian CDMO SimAbs, with the signing of a Quality Agreement that marks the successful completion of the first phase of the manufacturing preparation for sFilm-FS™. This agreement lays the foundation for GMP manufacturing and supports the preparation for large-scale clinical and commercial […]